|
🐜
|
p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
9 auth.
M. Pinyol,
F. Cobo,
S. Beá,
P. Jares,
I. Nayach,
P. Fernandez,
...
E. Montserrat,
A. Cardesa,
E. Campo
|
8 |
1998 |
8
🐜
|
|
🐜
|
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
14 auth.
F. Bosch,
A. Ferrer,
A. López-Guillermo,
E. Giné,
B. Bellosillo,
N. Villamor,
D. Colomer,
F. Cobo,
M. Perales,
J. Esteve,
...
A. Altés,
J. Besalduch,
J. Ribera,
E. Montserrat
|
7 |
2002 |
7
🐜
|
|
🐜
|
Identification of ‘short‐lived’ and ‘long‐lived’ patients at presentation of idiopathic myelofibrosis
7 auth.
F. Cervantes,
Arturo Pereira,
J. Esteve,
M. Rafel,
F. Cobo,
C. Rozman,
...
E. Montserrat
|
7 |
1997 |
7
🐜
|
|
🐜
|
Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome
32 auth.
G. Sanz,
B. Nomdedeu,
E. Such,
T. Bernal,
M. Belkaid,
M. Ardanaz,
V. Marco,
C. Pedro,
F. Ramos,
M. C. Cañizo,
E. Luño,
F. Cobo,
F. Carbonell,
V. Gómez,
J. Muñoz,
...
M. Amigo,
A. Bailén,
S. Bonanad,
M. Tormo,
R. Andreu,
B. Arrizabalaga,
M. Arilla,
J. Bueno,
M. Requena,
J. Bargay,
Joaquín Sánchez,
L. Senent,
L. Arenillas,
R. de Paz,
B. Xicoy,
R. Duarte,
J. Cervera
|
6 |
2008 |
6
🐜
|
|
🐜
|
Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas
11 auth.
J. Bladé,
M. Perales,
L. Rosiñol,
M. Tuset,
S. Montoto,
J. Esteve,
...
F. Cobo,
Luis Villela,
M. Rafel,
B. Nomdedeu,
E. Montserrat
|
6 |
2001 |
6
🐜
|
|
🐜
|
Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations
20 auth.
C. López,
J. Delgado,
D. Costa,
L. Conde,
G. Ghita,
N. Villamor,
A. Navarro,
M. Cazorla,
Cándida Gómez,
Amparo Arias,
...
C. Muñoz,
T. Baumann,
M. Rozman,
M. Aymerich,
D. Colomer,
F. Cobo,
E. Campo,
A. López-Guillermo,
E. Montserrat,
A. Carrió
|
6 |
2012 |
6
🐜
|
|
🐜
|
Existence of a platelet‐adhesion defect in patients with cirrhosis independent of hematocrit: Studies under flow conditions
8 auth.
A. Ordinas,
G. Escolar,
I. Cirera,
M. Viñas,
F. Cobo,
J. Bosch,
...
J. Terès,
J. Rodés
|
6 |
1996 |
6
🐜
|
|
🐜
|
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
51 auth.
A. Kuendgen,
M. Nomdedeu,
H. Tuechler,
G. Garcia-Manero,
R. Komrokji,
M. Sekeres,
M. D. Porta,
M. Cazzola,
A. DeZern,
G. Roboz,
D. Steensma,
A. A. Loosdrecht,
R. Schlenk,
R. Schlenk,
J. Grau,
...
X. Calvo,
S. Blum,
Arturo Pereira,
P. Valent,
D. Costa,
A. Giagounidis,
B. Xicoy,
H. Döhner,
U. Platzbecker,
C. Pedro,
M. Lübbert,
I. Oiartzabal,
M. Díez-Campelo,
M. Cedena,
S. Machherndl-Spandl,
M. López-Pavía,
C. Baldus,
M. Martinez-de-Sola,
R. Stauder,
B. Merchan,
A. List,
C. Ganster,
T. Schroeder,
M. Voso,
M. Pfeilstöcker,
H. Sill,
B. Hildebrandt,
J. Esteve,
B. Nomdedeu,
F. Cobo,
R. Haas,
F. Solé,
U. Germing,
P. Greenberg,
D. Haase,
G. Sanz
|
5 |
2020 |
5
🐜
|
|
🐜
|
Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia.
12 auth.
A. Muntañola,
F. Bosch,
P. Arguis,
E. Arellano-Rodrigo,
C. Ayuso,
E. Giné,
...
M. Crespo,
P. Abrisqueta,
C. Moreno,
F. Cobo,
A. López-Guillermo,
E. Montserrat
|
5 |
2007 |
5
🐜
|
|
🐬
|
The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades
F. Cervantes,
Arturo Pereira,
J. Esteve,
F. Cobo,
C. Rozman,
E. Montserrat
|
5 |
1998 |
5
🐬
|
